menu search

These 3 unique stocks have undeniable long-term upside

A tectonic demographic shift is boosting fertility specialist Progyny. Streaming is driving massive gro...

June 15, 2023, 9:30 am

Here's why you should invest in hologic (holx) stock now

Investors are optimistic about Hologic (HOLX) on continued strength in gyn Surgical and Breast Health b...

June 15, 2023, 9:17 am

Progyny, inc. to present at jefferies 2023 healthcare conference

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management...

June 5, 2023, 12:00 pm

Femtherapeutics raises $2.5 million cad to address pelvic floor disorders with custom vaginal prosthetics

FemTherapeutics has raised a $2.5-million CAD round to develop its technology for customizable gynecolo...

June 2, 2023, 10:14 am

Laparoscopy devices market size worth usd 247.48 billion by 2030 at 31.97% cagr – report by market research future (mrfr)

Laparoscopy Device Market Trends and Insights By Product Type (Laparoscopes, Energy Devices), By Application (General Surgery, ...

May 31, 2023, 5:16 pm

Endoscopy devices market size to surpass usd 25.3 billion by 2030 at 4.10% cagr – report by market research future (mrfr)

Endoscopy Device Market Trends and Insights By Type (Rigid endoscopes, Flexible endoscopes, Surgical endoscopes, Capsule endoscopes and Robot-assisted...

May 29, 2023, 3:00 pm

Aspira women's health to present at the 2023 american college of obstetricians and gynecologists annual clinical & scientific conference

AUSTIN, Texas, May 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company...

May 19, 2023, 8:00 am

Looking for a growth stock? 3 reasons why progyny (pgny) is a solid choice

Progyny (PGNY) possesses solid growth attributes, which could help it handily outperform the market....

May 17, 2023, 2:20 pm

Earnings estimates moving higher for progyny (pgny): time to buy?

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indica...

May 17, 2023, 1:33 pm

Why progyny caught my eye; is it a buy?

Sparsely followed Progyny, Inc. is quietly making industry waves. The target market is in its infant st...

May 16, 2023, 9:10 am

Surgical equipment market size is projected to surpass usd 36.0 bn by 2032 | cagr 8.2%

As Per Market.us Study, The global market for surgical equipment is divided into orthopedic, neurosurgery, gyn...

May 15, 2023, 1:44 pm

Progyny, inc. (pgny) q1 2023 earnings call transcript

Progyny, Inc. (NASDAQ:PGNY ) Q1 2023 Earnings Conference Call May 8, 2023 4:45 PM ET Company Participan...

May 8, 2023, 11:20 pm

Hologic's (holx) q2 earnings beat estimates, 2023 view up

The year-over-year growth in Breast Health and gyn Surgical Businesses contributed to Hologic's (HOLX) ...

May 2, 2023, 1:43 pm

Progyny, inc. to present at bank of america health care conference 2023

NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management ...

May 2, 2023, 12:00 pm

4 growth stocks to buy and hold forever

CrowdStrike and Progyny offer best-in-class solutions to two of today's biggest problems. Texas Pacific...

April 27, 2023, 5:35 am

Progyny and fertility matters canada honour canadian fertility awareness week with a call to increase access to family building care

The organizations will be hosting an event to commemorate the CN Tower being lit green in support of the millions of people who need family building c...

April 19, 2023, 3:10 pm

Eisai to present research from oncology portfolio at the society of gynecologic oncology (sgo) 2023 annual meeting on women's cancer

Study Findings in Patients with Recurrent or Advanced Endometrial Carcinoma Who Were Rechallenged With Platinum Chemotherapy Will Be Featured in an Or...

March 23, 2023, 8:08 am

Progyny, inc. to present at keybanc life sciences & medtech investor forum

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits managemen...

March 20, 2023, 12:00 pm

Celcuity to present preclinical data on therapeutic effects of gedatolisib in gynecological cancer models at aacr annual meeting 2023

MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted...

March 15, 2023, 7:35 pm

Why shares of progyny rose 18.4% this week

The company reported record revenue at the beginning of the week....

March 3, 2023, 5:56 pm


Search within

Pages Search Results: